Please answer #1, #2, #3, and #4 and explain as to why you chose those answers. Thanks!

BioMD Partners II is a VC fund that raised $200 million from major investors, such as the Gondour Public Pension Fund (GPPF), to invest in DNA manipulation using CRISPR. It has invested in three different companies: Nutcracker, Aldevron, and GenScript. Qestion 1 (10 points) Saved Whose entity is more likely to be the GP? Gondour Public Pension Fund Aldevron BioMD Partners II CRISPR BioMD Partners Whose business entity is more likely to be the Limited Partnership? BioMD Partners II Aldevron CRISPR BioMD Partners Gondour Public Pension Fund uestion 3 (10 points) Whose business entity is more likely to be a Limited Partner? CRISPR Gondour Public Pension Fund Aldevron BioMD Partners BioMD Partners II Uestion 4 (10 points) The $200 million is... The target capital The committed capital The distributed capital The investment capital